Advisors Capital Management Position in Thermo Fisher Scientific (TMO) Has Cut by $498,248; Las Vegas Sands (LVS) Shareholder Zurcher Kantonalbank Zurich Cantonalbank Lowered Its Position by $6.69 Million

Las Vegas Sands Corp. (NYSE:LVS) Logo

Zurcher Kantonalbank Zurich Cantonalbank decreased its stake in Las Vegas Sands Corp (LVS) by 60.63% based on its latest 2018Q3 regulatory filing with the SEC. Zurcher Kantonalbank Zurich Cantonalbank sold 113,465 shares as the company’s stock declined 12.65% with the market. The institutional investor held 73,665 shares of the hotels and resorts company at the end of 2018Q3, valued at $4.37M, down from 187,130 at the end of the previous reported quarter. Zurcher Kantonalbank Zurich Cantonalbank who had been investing in Las Vegas Sands Corp for a number of months, seems to be less bullish one the $44.62B market cap company. The stock increased 0.41% or $0.23 during the last trading session, reaching $56.96. About 2.25M shares traded. Las Vegas Sands Corp. (NYSE:LVS) has declined 23.19% since January 11, 2018 and is downtrending. It has underperformed by 23.19% the S&P500. Some Historical LVS News: 19/03/2018 – Las Vegas Sands Completes Amendment And Restatement Of Its Marina Bay Sands Credit Facility; 08/03/2018 – Las Vegas Sands Sells Pennsylvania Casino to Native American Tribe for $1.3 Billion; 08/03/2018 – LAS VEGAS SANDS TO SELL SANDS BETHLEHEM TO WIND CREEK; 08/03/2018 – LAS VEGAS SANDS – ENTERED AGREEMENT UNDER WHICH WIND CREEK HOSPITALITY WILL BUY SANDS BETHLEHEM PROPERTY IN PENNSYLVANIA; 25/04/2018 – LAS VEGAS SANDS 1Q NET REV. $3.58B; 31/05/2018 – Sands China Hosts Third Invitational Matching Session for Local SME Suppliers; 26/04/2018 – LAS VEGAS SANDS CORP LVS.N : JP MORGAN RAISES TARGET PRICE TO $76 FROM $74; 03/04/2018 – Casino Guidelines in Japan Could Benefit MGM, Las Vegas Sands; 08/03/2018 – LAS VEGAS SANDS AGREES TO $1.3B SALE OF SANDS BETHLEHEM; 19/04/2018 – LAS VEGAS SANDS CORP LVS.N : NOMURA RAISES TARGET PRICE TO $69 FROM $67

Advisors Capital Management Llc decreased its stake in Thermo Fisher Scientific Inc (TMO) by 3.35% based on its latest 2018Q3 regulatory filing with the SEC. Advisors Capital Management Llc sold 2,042 shares as the company’s stock declined 0.05% with the market. The institutional investor held 58,912 shares of the industrial machinery and components company at the end of 2018Q3, valued at $14.38 million, down from 60,954 at the end of the previous reported quarter. Advisors Capital Management Llc who had been investing in Thermo Fisher Scientific Inc for a number of months, seems to be less bullish one the $96.62 billion market cap company. The stock increased 0.48% or $1.14 during the last trading session, reaching $240. About 1.36 million shares traded. Thermo Fisher Scientific Inc. (NYSE:TMO) has risen 27.72% since January 11, 2018 and is uptrending. It has outperformed by 27.72% the S&P500. Some Historical TMO News: 13/04/2018 – Global Gas Analyzer Market Forecast to 2023 with ABB Group, Emerson Electric, General Electric, Figaro Engineering, and Thermo Fishers Scientific Dominating – ResearchAndMarkets.com; 25/04/2018 – Thermo Fisher 1Q Adj EPS $2.50; 27/04/2018 – THERMO FISHER & LEICA COLLABORATE TO DEVELOP INTEGRATED; 05/04/2018 – ORTHO CLINICAL DIAGNOSTICS SAYS ASSAYS WILL INITIALLY BE LAUNCHED IN NORTH AMERICA, EUROPE, AFRICA AND MIDDLE EAST; 27/04/2018 – Thermo Fisher and Leica Collaborate to Develop Integrated Cryo-tomography Workflow Solution; 28/03/2018 – BIOCEPT INC – ENTERED INTO A NON-BINDING MEMORANDUM OF UNDERSTANDING WITH THERMO FISHER SCIENTIFIC, INC. TO COLLABORATE TOGETHER COMMERCIALLY; 01/05/2018 – Thermo Fisher Scientific Signs New Agreements to Expand Oncomine Dx Target Test; 25/04/2018 – Thermo Fisher Sees FY Adj EPS $10.80-Adj EPS $10.96; 25/04/2018 – Thermo Fisher 1Q Organic Revenue Growth 7%; 16/05/2018 – Testing for all lung cancer mutations at once found cost effective-study

Advisors Capital Management Llc, which manages about $763.81M and $1.53 billion US Long portfolio, upped its stake in Qualcomm Inc (NASDAQ:QCOM) by 5,197 shares to 617,118 shares, valued at $44.45M in 2018Q3, according to the filing. It also increased its holding in Starwood Ppty Tr Inc (NYSE:STWD) by 24,525 shares in the quarter, for a total of 524,708 shares, and has risen its stake in Topbuild Corp.

Since October 1, 2018, it had 0 insider buys, and 5 insider sales for $39.04 million activity. On Friday, December 7 Williamson Stephen sold $2.29 million worth of Thermo Fisher Scientific Inc. (NYSE:TMO) or 9,500 shares. 125,520 Thermo Fisher Scientific Inc. (NYSE:TMO) shares with value of $31.07 million were sold by CASPER MARC N. 17,235 shares were sold by Herrema Gregory J., worth $4.26 million on Thursday, November 29.

Among 20 analysts covering Thermo Fisher Scientific (NYSE:TMO), 17 have Buy rating, 0 Sell and 3 Hold. Therefore 85% are positive. Thermo Fisher Scientific had 74 analyst reports since July 24, 2015 according to SRatingsIntel. Goldman Sachs downgraded Thermo Fisher Scientific Inc. (NYSE:TMO) on Monday, September 17 to “Neutral” rating. Goldman Sachs initiated Thermo Fisher Scientific Inc. (NYSE:TMO) rating on Tuesday, September 26. Goldman Sachs has “Buy” rating and $225.0 target. Cowen & Co maintained Thermo Fisher Scientific Inc. (NYSE:TMO) rating on Wednesday, October 25. Cowen & Co has “Buy” rating and $220.0 target. Cowen & Co maintained it with “Buy” rating and $220.0 target in Friday, September 8 report. Jefferies downgraded the stock to “Hold” rating in Friday, April 29 report. The rating was maintained by Morgan Stanley on Thursday, April 26 with “Overweight”. Robert W. Baird maintained Thermo Fisher Scientific Inc. (NYSE:TMO) rating on Thursday, October 25. Robert W. Baird has “Outperform” rating and $264 target. The stock of Thermo Fisher Scientific Inc. (NYSE:TMO) earned “Buy” rating by Deutsche Bank on Thursday, January 7. The firm has “Overweight” rating by Morgan Stanley given on Wednesday, October 10. The rating was maintained by Deutsche Bank with “Buy” on Thursday, October 26.

Investors sentiment decreased to 0.85 in 2018 Q3. Its down 0.23, from 1.08 in 2018Q2. It dived, as 41 investors sold TMO shares while 434 reduced holdings. 111 funds opened positions while 295 raised stakes. 333.46 million shares or 0.38% more from 332.19 million shares in 2018Q2 were reported. 165,696 were accumulated by Fil. Trustco National Bank & Trust Corporation N Y holds 1,151 shares or 0.3% of its portfolio. Northwestern Mutual Wealth Management stated it has 56,896 shares or 0.07% of all its holdings. 168,917 are owned by Caledonia Investments Public Limited Com. Payden And Rygel holds 0.01% in Thermo Fisher Scientific Inc. (NYSE:TMO) or 700 shares. Country Club Na owns 25,152 shares or 0.71% of their US portfolio. Mountain Pacific Inv Advisers Id accumulated 60,310 shares. Round Table Limited Co holds 0.11% in Thermo Fisher Scientific Inc. (NYSE:TMO) or 1,362 shares. Tuttle Tactical Management owns 20,100 shares. Osborne Cap Management Ltd Company owns 39,919 shares. Comerica Bank & Trust reported 126,233 shares. 14,016 are owned by Strategy Asset Managers Limited Company. Cap Management New York accumulated 0.91% or 3,000 shares. Sheets Smith Wealth Management holds 0.12% or 2,423 shares. Segment Wealth Mngmt Ltd Company reported 0.07% of its portfolio in Thermo Fisher Scientific Inc. (NYSE:TMO).

More notable recent Thermo Fisher Scientific Inc. (NYSE:TMO) news were published by: Benzinga.com which released: “Thermo Fisher Scientific Inc (NYSE:TMO) – Q3 Earnings Preview: Thermo Fisher Scientific – Benzinga” on October 23, 2018, also Seekingalpha.com with their article: “Thermo Fisher Scientific declares $0.17 dividend – Seeking Alpha” published on November 08, 2018, Seekingalpha.com published: “Thermo Fisher in-licenses CRISPR technologies – Seeking Alpha” on September 18, 2018. More interesting news about Thermo Fisher Scientific Inc. (NYSE:TMO) were released by: Seekingalpha.com and their article: “Thermo Fisher Scientific (TMO) Investor Presentation – Slideshow – Seeking Alpha” published on May 25, 2018 as well as Seekingalpha.com‘s news article titled: “Thermo Fisher launches Ion AmpliSeq HD technology – Seeking Alpha” with publication date: June 18, 2018.

Analysts await Thermo Fisher Scientific Inc. (NYSE:TMO) to report earnings on January, 30 before the open. They expect $3.19 EPS, up 14.34% or $0.40 from last year’s $2.79 per share. TMO’s profit will be $1.28 billion for 18.81 P/E if the $3.19 EPS becomes a reality. After $2.62 actual EPS reported by Thermo Fisher Scientific Inc. for the previous quarter, Wall Street now forecasts 21.76% EPS growth.

Analysts await Las Vegas Sands Corp. (NYSE:LVS) to report earnings on January, 23. They expect $0.86 earnings per share, down 2.27% or $0.02 from last year’s $0.88 per share. LVS’s profit will be $673.67 million for 16.56 P/E if the $0.86 EPS becomes a reality. After $0.77 actual earnings per share reported by Las Vegas Sands Corp. for the previous quarter, Wall Street now forecasts 11.69% EPS growth.

Among 25 analysts covering Las Vegas Sands (NYSE:LVS), 13 have Buy rating, 0 Sell and 12 Hold. Therefore 52% are positive. Las Vegas Sands had 76 analyst reports since July 23, 2015 according to SRatingsIntel. On Thursday, January 25 the stock rating was maintained by Roth Capital with “Buy”. The firm earned “Buy” rating on Friday, September 1 by Stifel Nicolaus. As per Thursday, October 26, the company rating was maintained by Nomura. The company was maintained on Wednesday, July 27 by Barclays Capital. HSBC upgraded the stock to “Buy” rating in Tuesday, October 16 report. The rating was maintained by CLSA on Monday, September 19 with “Outperform”. Nomura maintained Las Vegas Sands Corp. (NYSE:LVS) on Monday, July 9 with “Neutral” rating. Stifel Nicolaus maintained the shares of LVS in report on Friday, November 4 with “Buy” rating. The firm has “Buy” rating by Citigroup given on Wednesday, April 13. Deutsche Bank maintained the stock with “Hold” rating in Wednesday, October 19 report.

Since September 6, 2018, it had 0 insider purchases, and 1 insider sale for $4.06 million activity.

Investors sentiment decreased to 0.99 in Q3 2018. Its down 0.25, from 1.24 in 2018Q2. It dived, as 65 investors sold LVS shares while 180 reduced holdings. 83 funds opened positions while 160 raised stakes. 278.58 million shares or 4.69% less from 292.30 million shares in 2018Q2 were reported. Janney Mngmt Limited Liability Company accumulated 0.04% or 76,292 shares. Mackay Shields Ltd Company has 25,570 shares for 0.01% of their portfolio. Barr E S reported 33,165 shares stake. Artemis Inv Mgmt Llp has invested 0.2% in Las Vegas Sands Corp. (NYSE:LVS). Douglass Winthrop Advsr Lc holds 0.02% of its portfolio in Las Vegas Sands Corp. (NYSE:LVS) for 6,000 shares. Brandywine Glob Investment Mngmt Limited Liability has invested 0.08% in Las Vegas Sands Corp. (NYSE:LVS). Paloma Prtnrs Mgmt has 33,544 shares for 0.04% of their portfolio. Virginia Retirement Et Al accumulated 79,200 shares. Korea Corporation invested in 279,585 shares. S&Co accumulated 5,700 shares or 0.04% of the stock. Comerica Inc holds 43,200 shares. Moors And Cabot reported 0.06% stake. 69 are held by Wilbanks Smith & Thomas Asset Mgmt Ltd Liability Corporation. Td Asset Mgmt holds 268,876 shares or 0.02% of its portfolio. State Street owns 7.43 million shares or 0.03% of their US portfolio.

Thermo Fisher Scientific Inc. (NYSE:TMO) Institutional Positions Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.